Mrv1909 12271913382D 16 17 0 0 0 0 999 V2000 0.9332 -1.1664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.6316 -2.6184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.1631 0.1434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2658 2.6184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.2658 0.1434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.4487 1.3809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.1466 -1.9510 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.2658 -0.6815 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.4016 -1.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6783 -1.9510 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.1631 -2.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4487 0.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9802 0.5559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9802 1.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2658 1.7934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.8916 1.6367 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 8 1 0 0 0 0 1 10 1 0 0 0 0 7 2 1 1 0 0 0 3 12 2 0 0 0 0 4 15 2 0 0 0 0 8 5 1 6 0 0 0 5 12 1 0 0 0 0 5 13 1 0 0 0 0 6 12 1 0 0 0 0 6 15 1 0 0 0 0 6 16 1 0 0 0 0 7 9 1 0 0 0 0 7 10 1 0 0 0 0 8 9 1 0 0 0 0 10 11 1 6 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 M END > DB03274 > drugbank > [H]N1C(=O)C=CN([C@H]2C[C@H](O)[C@@H](C)O2)C1=O > InChI=1S/C9H12N2O4/c1-5-6(12)4-8(15-5)11-3-2-7(13)10-9(11)14/h2-3,5-6,8,12H,4H2,1H3,(H,10,13,14)/t5-,6+,8-/m1/s1 > FDCFKLBIAIKUKB-GKROBHDKSA-N > C9H12N2O4 > 212.2026 > 212.079706882 > 4 > 27 > -0.0019652641351258176 > 19.959067728286886 > 1 > 2 > 0 > 0 > 1-[(2R,4S,5R)-4-hydroxy-5-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione > -0.4676941119999997 > 0 > 0 > 2 > 0 > 14.091576401055807 > 9.705742647755976 > -3.203144908644203 > 78.87 > 49.511199999999995 > 1 > 1 > N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl]cyclopentanecarboxamide > 0 > DB03274 > EXPT01151 > experimental > 2',5'-Dideoxyuridine $$$$